This document provides an overview of the public drug plans in each province in alphabetical order. Read more on who qualifies for the program, what the deductible, premium and co payment is, who pays for medications first and where additional information can be...
Arthritis and COVID19 vaccines – an educational webinar and panel discussion moderated by Dr. Dawn Richards, CAPA’s Vice-President In this video, CAPA’s Vice-President Dr. Dawn Richards moderates an educational webinar and leads panel discussion on...
CAPA believes that people need to have access to information and research to be able to find their voice and help take control of their disease. We developed these tips for chronic pain based on the responses to a survey in 2018 and a Twitter chat held during National...
You have heard about clinical trials, but are unsure about what they are, and what it means to participate. This infographic has been developped by Clinical Trials Ontario to help navigate. It provides an explanation of what clinical trials are, the different phases...
There are a number of biosimilar medications available to treat people with arthritis in Canada. A biosimilar is a biologic drug that is highly similar to a biologic drug that was already authorized for sale. Health Canada has recently updated its fact sheet on...
Clinical trials are an key part of the research process. If you’re thinking about participation in a clinical trial, CAPA encourages you to read up on clinical trials and make a decision that is right for you. Below are some resources to help get you started where...
English 
Français du Canada